RetrieverResults

13/07/2025

Heads up, Mid-Atlantic states! That tick bite could be more serious than you think. Deer ticks are increasingly carrying both Lyme disease and babesiosis, a malaria- like illness. This co- infection can make diagnosis and treatment much trickier.

Learn how this emerging public health concern is spreading into Maryland, Virginia, Delaware, and Washington D.C. and how you can protect yourself.

https://dha.mil/News/2025/07/10/13/53/Babesiosis-Lyme-Disease-Emerging-Co-Infection-Threat-from-Deer-Ticks-in-Maryland

13/07/2025

the AHS recently revamped their Canine Heartworm Guidelines, with some important updates. AHS President Dr. Jennifer Rizzo shares what you need to know in this VETgirl post. https://bit.ly/4io4TiS

09/07/2025

https://www.akcchf.org/educational-resources/library/articles/cool-down-science-how-a-simple-head-dunk-could-save-your-dog-from-heat-stroke/?fbclid=IwY2xjawLbm9JleHRuA2FlbQIxMQBicmlkETFwTWF6R1VKUEd4eXF6SVIxAR7-ySu6AOHo5X6YvHfWARRADXIvLEjyQED8ibk5MzsuWdb223W4Ot_pV-5kJw_aem_HcfdNmoi_wab7Z2IuYm9Cg

Summer brings long days of sunshine and outdoor adventure and for many dogs, that means backyard play, long hikes, training sessions, or athletic competitions. But with rising temperatures comes a real danger: heat injury. Just as you might crave air conditioning and ice water after time outside, yo...

02/07/2025

The University of Minnesota's Clinical Investigation Center (CIC) has an open trial called "Canine brain tumor trials: Glioma". The goal of the Canine Brain Tumor Clinical Trial Program, which has multiple trials, is to offer cutting-edge therapy to dogs intended to preserve quality of life and improve long-term survival rates. Additionally, they will use the information gained from treating dogs to design similar treatments for people with brain tumors. If you have dog(s) with glioma, as seen on MRI, read more information here: z.umn.edu/aham

02/07/2025

To anyone who regularly works with both show-line and working-line German Shepherds, it will come as no surprise that a 2019 study (Sarviaho R, Hakosalo O, Tiira K, et al.) analyzing over 173,000 genetic markers across 330 German Shepherd Dogs confirmed that show lines and working lines are in fact genetically distinct populations.

Working lines have been selectively bred for traits like nerve, drive, aggression, and functional performance, whereas show lines shifted their focus to appearance, conformation, and movement for the show ring. Over time, this prioritization of looks over ability has significantly reduced the working capacity and temperament of show-line dogs.

Despite these genetic and functional differences, kennel clubs still register both lines as the same breed. As a consequence, the standards and judging of the breed survey have been progressively watered down to ensure show-line dogs can continue to pass. Similarly, IGP has gradually lowered its standards at least in part to allow show-line dogs to remain competitive.

But this erosion of standards doesn’t just impact show lines. It ultimately harms working lines, too. By continually making it easier for dogs bred without true working temperament to participate, the incentive to maintain real, breed-specific working traits diminishes.

This is not intended to be an attack on show line dogs or breeders. I own a show line GSD and I love her to death. But we must speak honestly about what is happening to our breed as the traits beloved by working dog handlers are set aside in favour of traits that make for better pets or better performance in the show ring. Breeds don’t lose their identity overnight. They lose it through a cycle of lowered expectations.

02/07/2025

30/06/2025

Metastatic Osteosarcoma Clinical Trial
The Comparative Immunotherapy Program at Penn Vet is starting a new clinical trial to treat dogs with osteosarcoma, a horrible disease that occurs often in large breed dogs, including Labrador Retrievers.

Led by Nicola Mason, program director, and Antonia Rotolo, the director of effector cell therapies, both of the Comparative Immunotherapy Program at Penn Vet, the trial is investigating the safety and therapeutic potential of genetically engineered white blood cells, known as invariant natural killer T cells (CAR-iNKT), to target metastatic cancer cells. You may have just seen their work highlighted in a PBS documentary, “Shelter Me: Cancer Pioneers”.

More information on the trial can be found here. https://veterinaryclinicaltrials.org/study/VCT24005853.

28/06/2025

😂

28/06/2025

Up to 10% of people experience lingering, serious symptoms.

26/06/2025

25/06/2025

https://www.facebook.com/share/r/16kQJZNWJ9/?mibextid=wwXIfr

25/06/2025